Cargando…
B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer
B7-H1 and B7-H3, two members of the B7 family that are thought to regulate T-cell activation, are expressed in human non-small cell lung cancer (NSCLC). However, their prognostic significance is poorly understood. In the present study we reported that B7-H1 and B7-H3 were expressed in 96/128 (72.7%)...
Autores principales: | Mao, Yixiang, Li, Wei, Chen, Kai, Xie, Yufeng, Liu, Qiang, Yao, Min, Duan, Weiming, Zhou, Xiumin, Liang, Rongrui, Tao, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413666/ https://www.ncbi.nlm.nih.gov/pubmed/25609202 |
Ejemplares similares
-
High expression of B7-H2 or B7-H3 is associated with poor prognosis in hepatocellular carcinoma
por: Zheng, Youshi, et al.
Publicado: (2019) -
B7-H4 is Predictive of Poor Prognosis in Patients with Gastric Cancer
por: Cui, YongHui, et al.
Publicado: (2016) -
Overexpression of B7-H3 Is Associated With Poor Prognosis in Laryngeal Cancer
por: Li, Yixuan, et al.
Publicado: (2021) -
Co-deficiency of B7-H3 and B7-H4 identifies high CD8 + T cell infiltration and better prognosis in pancreatic cancer
por: Si, Shuping, et al.
Publicado: (2022) -
Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer
por: Marx, Andreas, et al.
Publicado: (2021)